Pipeline Vantage Embolization Device with Shield Technology
FDA premarket approval P100018/S034 · decided 2023-09-15
Approval details
- PMA number
- P100018
- Supplement
- S034
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Pipeline Vantage Embolization Device with Shield Technology
- Generic name
- Intracranial aneurysm flow diverter
- Applicant
- Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
- Date received
- 2021-09-27
- Decision date
- 2023-09-15
- Days to decision
- 718 days
- Decision code
- APPR
- Product code
- OUT
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Irvine, CA
- Statement
- Approval for a new neurovascular flow-diverting stent and delivery system in the Pipeline product family.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.